Roxicodone and Armodafinil drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Roxicodone (oxycodone hydrochloride) and Armodafinil (armodafinil). Common drug interactions include decreased appetite among females and abdominal pain among males.
The phase IV clinical study analyzes what interactions people have when they take Roxicodone and Armodafinil. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Roxicodone?
Roxicodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 20,099 Roxicodone users. Check the latest studies of Roxicodone.
What is Armodafinil?
Armodafinil has active ingredients of armodafinil. It is often used in narcolepsy. eHealthMe is studying from 4,136 Armodafinil users. Check the latest studies of Armodafinil.
12 people who take Roxicodone and Armodafinil together, and have interactions are studied.

What are the common drug interactions of Roxicodone and Armodafinil, by gender? *:
female:
- Decreased appetite
- Decreased interest
- Dyspnoea (difficult or laboured respiration)
- Fracture nonunion (permanent failure of healing following a broken bone)
- Gait disturbance
- Headache (pain in head)
- Hepatic lesion
- Hepatic steatosis (fatty liver disease)
- Hyperlipidaemia (presence of excess lipids in the blood)
- Hyperthyroidism (over activity of the thyroid gland)
male:
- Abdominal pain
- Anaemia (lack of blood)
- Calculus ureteric (stone in ureter)
- Cellulitis (infection under the skin)
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Compression fracture (fracture due to pressure caused by injury)
- Costochondritis (chest wall pain)
- Deafness
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Dental caries
What are the common drug interactions of Roxicodone and Armodafinil, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Candidiasis (candidiasis or thrush is a fungal infection)
- Cardiomegaly (increased size of heart than normal)
- Cerebral atrophy (decrement in size of brain)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Constipation
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Cough
- Decreased interest
- Dyspnoea (difficult or laboured respiration)
50-59:
- Arthralgia (joint pain)
- Delusion (a false belief or opinion)
- Hallucination (an experience involving the perception of something not present)
- Myalgia (muscle pain)
60+:
- Abdominal adhesions (inflammation of abdomen)
- Asthenia (weakness)
- Postoperative wound infection
- Small intestinal obstruction (blockage in small intestine)
- Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
- Decreased appetite
- Gait disturbance
- Hypoaesthesia (reduced sense of touch or sensation)
- Secretion discharge
- Urinary incontinence (inability to control the flow of urine and involuntary urination)
What are the existing conditions these people have? *
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 25.00%
- High Blood Pressure: 2 people, 16.67%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 16.67%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 16.67%
- Breast Cancer: 2 people, 16.67%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
- Pain In Extremity: 1 person, 8.33%
- Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
- Neuralgia (pain in one or more nerves): 1 person, 8.33%
- Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Roxicodone and Armodafinil?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Roxicodone (20,099 reports)
- Armodafinil (4,136 reports)
Browse all drug interactions of Roxicodone and Armodafinil:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Roxicodone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Armodafinil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Roxicodone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Armodafinil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on oxycodone hydrochloride and armodafinil (the active ingredients of Roxicodone and Armodafinil, respectively), and Roxicodone and Armodafinil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Benzonatate and Valcyte - now
- How effective is Mobic for Joint Pain? - 3 seconds ago
- Drug interactions of Dobutamine Hydrochloride and Heparin Sodium - 5 seconds ago
- Drug interactions of Benzonatate and Betamethasone Dipropionate - 7 seconds ago
- Drug interactions of Vesicare and B12 - 12 seconds ago
- Could Magnesium cause Reticulocyte Count Decreased? - 17 seconds ago
- How effective is Amiloride Hydrochloride for High Blood Pressure? - 25 seconds ago
- Tension Headache and Malaise - 28 seconds ago
- Could Loraz cause Hypertensive Crisis? - 29 seconds ago
- How effective is Bayer Low Dose Aspirin (81Mg Aspirin) for Blood Clots? - 29 seconds ago